期刊文献+

老年胶质母细胞瘤患者预后影响因素分析 被引量:7

Analysis of clinical,pathological features and therapeutic treatments in predicting prognosis of elderly glioblastomas
原文传递
导出
摘要 目的探讨Ki67和异柠檬酸脱氢酶(IDH)在老年(年龄≥65岁)胶质母细胞瘤(GBM)中的表达以及性别、卡氏(KPS)评分、切除程度和放化疗等临床因素与老年GBM患者预后之间的潜在关系。方法对象为郑州大学第一附属医院2013至2018年间收治的老年GBM患者,共54例。采用链霉卵白素-过氧化物酶法(SP)检测Ki67表达情况,采用Sanger测序的方法检测IDH突变情况。最终进行统计学分析以确定Ki67指数、IDH突变、性别、KPS评分、切除程度以及放化疗是否与患者的临床预后具有相关性。结果54例老年GBM患者均没有检测到IDH突变。单因素分析表明,Ki67指数(P=0.033)、KPS评分(P=0.008)和切除程度(P<0.001)是与老年GBM患者预后相关的影响因素之一。术后是否进行辅助放化疗与患者的预后具有明显相关性,进行放疗(P=0.002)和化疗(P=0.034)的患者具有更长的生存期。而性别(P=0.467)与本组患者的预后没有明显相关性。多因素分析表明,放疗(OR值2.446,P=0.009)及切除程度(OR值6.976,P<0.001)是老年GBM患者预后的独立预测因子。结论IDH突变在老年GBM中确实罕见,提示老年GBM患者往往具有预后不良的分子病理学表型。Ki67、KPS评分、切除程度和放化疗是影响患者预后的因素。 Objective This study was designed to investigate prognostic factors and the potential relationship between the expression of Ki67 and IDH of glioblastoma in the elderly(≥65 years old)and the clinical factors such as gender,the KPS score and treatments including surgical resection,radiotherapy and chemotherapy and the prognosis of such patients.Methods Fifty-four elderly patients(≥65 years old)with glioblastoma admitted to the First Affiliated Hospital of Zhengzhou University from 2013 to 2018 were enrolled in this study.The expression of Ki67 was detected by immunohistochemical SP method and the mutation of IDH was detected by Sanger sequencing.Finally,statistical analysis was performed to determine whether Ki67,the mutation of IDH,gender,the KPS score and the extent of resection,radiotherapy and chemotherapy were associated with the clinical prognosis of the patients.Results Of the 54 elderly patients with glioblastoma,none was detected with IDH mutation.Univariate analysis showed that Ki67(P=0.033),the KPS score(P=0.008),the extent of resection(P<0.001)were factors influencing the prognosis of elderly patients with glioblastoma.Patients receiving postoperative adjuvant radiotherapy(P=0.002)and chemotherapy(P=0.034)had longer survival time.There was no significant correlation between gender(P=0.467)and prognosis.Multivariate analysis demonstrated that radiotherapy(OR 2.446,P=0.009)and the extent of resection(OR 6.976,P<0.001)were independent prognostic factors.Conclusions No IDH mutation was detected in all the patients in this study,indicating that IDH mutation is indeed rare in elderly glioblastoma,which suggests that geriatric population often harbor a molecular phenotype with poor prognosis.Ki67,KPS score,the extent of resection,radiotherapy and chemotherapy were the factors influencing the prognosis of patients.
作者 王艳敏 段文超 王伟伟 赵亚鹏 刘献志 张振宇 Wang Yanmin;Duan Wenchao;Wang Weiwei;Zhao Yapeng;Liu Xianzhi;Zhang Zhenyu(Department of Neurosurgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China;Department of Pathology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第2期121-124,共4页 National Medical Journal of China
基金 国家自然科学基金(81702465,U1804172)。
关键词 老年胶质瘤 胶质母细胞瘤 KI67 IDH 预后 Elderly glioma Glioblastoma Ki67 IDH Prognosis
  • 相关文献

参考文献5

二级参考文献30

  • 1章翔,张剑宁,费舟,傅洛安,刘卫平,贺晓生,蒋晓帆,高大宽,李峡,梁景文.神经导航显微手术切除颅内肿瘤[J].中华显微外科杂志,2005,28(2):116-118. 被引量:6
  • 2张志明.64例神经胶质瘤术后介入化疗评价[J].天津医药,2005,33(9):582-583. 被引量:2
  • 3胡永善.脑卒中三级康复治疗方案的探讨[J].中华全科医师杂志,2005,4(12):712-714. 被引量:45
  • 4范月超,雷霆,王雄伟,张洪涛,舒凯,李龄,薛德麟.老年人脑肿瘤163例临床分析[J].中华老年医学杂志,2006,25(3):186-188. 被引量:8
  • 5Lieu AS, Howng SL. Surgical treatment of intracranial meningiomas in geriatric patients. Kaohsiung J Med Sci, 1998,14 : 498 - 503. 被引量:1
  • 6Pietila TA, Stendel R, Hassler WE, et al. Brain tumor surgery in geriatric patients:a critical analysis in 44 pa- tients over 80 years. Surg Neurol, 1999,52 : 259 - 264. 被引量:1
  • 7Roger EP, Butler J, Benzel EC. Neurosurgery in the el- derly: brain tumors and subdural hematomas. Clin Geriatr Med,2006,22 : 623 - 644. 被引量:1
  • 8Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005,352(10) :987-996. DOI: 10. 1056/NEJMoa043330. 被引量:1
  • 9Westphal M, Heese O, Steiubach JP, et al. A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma [ J ]. Eur J Cancer, 2015,51 ( 4 ) : 522-532. DOI: 10. 1016/j. ejca. 2014.12. 019. 被引量:1
  • 10Wu JS, Gong X, Song YY, et al. 3.0-T intraoperative magnetic resonance imaging-guided resection in cerebral glioma surgery: interim analysis of a prospective, randomized, triple-blind, parallel-controlled trial [ J ]. Neurosurgery, 2014,61 Suppl 1 : 145-154. DOI: 10. 1227/NEU. 0000000000000372. 被引量:1

共引文献116

同被引文献56

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部